Navigation Links
BioLife Solutions Announces FDA Master File Acceptance for CryoStor(TM) Pre-formulated Cryopreservation Media
Date:5/8/2008

BOTHELL, Wash., May 8 /PRNewswire-FirstCall/ -- BioLife Solutions Inc. (OTC Bulletin Board: BLFS), a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced that its Master File for CryoStor cryopreservation media has been accepted by the United States Food and Drug Administration (FDA).

BioLife Chairman and Chief Executive Mike Rice commented: "We believe that the FDA Master File for CryoStor will provide clinical researchers and commercial partners easier access to our best-in-class cryopreservation media and facilitate faster product development of cell and tissue based products. Although classified as excipient materials, our sterile products are manufactured under medical device quality regulations and are made from only USP or the highest available grade components.

"We're optimistic that having an FDA Master File will also help accelerate product adoption in our key clinical markets, including cell therapy and cord blood and cell banking," Rice continued. "Our value proposition centers on providing the highest quality off-the-shelf and ready-to-use biopreservation media products with what is now the best regulatory footprint in the industry. Referencing our Master File should take some of the regulatory burden off our customers, so they can focus more time and resources on product development and clinical therapies."

More than 100 development-stage cell therapy companies have evaluated or adopted HypoThermosol(R) and/or CryoStor in the production of novel cell-based products targeting a multitude of diseases and disorders such as cancer, heart failure, vision loss, and neurologic disorders. In addition, TriMark Publications, LLC, a global leader in market research and intelligence for biotechnology, healthcare and life sciences, forecasts the global market for stem cell products and services to $104 billion by 2012. PA Consulting Group, a
'/>"/>

SOURCE BioLife Solutions Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioLife Solutions Outsourcing Manufacturing, Warehousing, and Order Fulfillment to Bioserv Corporation
2. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
3. BioLife Solutions Expands Scientific Advisory Board
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Basil Zimmo Joins Finesse Solutions as Vice-President of Software
6. Caliper Life Sciences and DiscoveRx Collaborate to Offer Solutions for Cell-Based GPCR Profiling and Lead Optimization
7. VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc.
8. Finesse Solutions Introduces the TruViu(TM) PLSS System
9. Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership
10. MBF Healthcare Acquisition Corp. and Critical Homecare Solutions Holdings, Inc. to Present at the 33rd Annual Deutsche Bank Healthcare Conference
11. InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015 Pfenex ... engaged in the development of biosimilar therapeutics including ... today that its first quarter 2015 financial results ... before the open of market. At 8:30 am Eastern ... to discuss the financial results and provide a ...
(Date:5/1/2015)... , May 1, 2015 ... Production Market by Product (Equipment, Consumables), by Type (Monoclonal, ... Diagnostic Labs, Research Institutes) - Analysis & Global ... studies the global Antibody Production Market for the ... is expected to reach $2.572 Billion by 2019 ...
(Date:4/30/2015)... CA (PRWEB) April 30, 2015 Cytokinetics, Incorporated ... first quarter of 2015 were $4.4 million, compared to $8.0 ... loss for the first quarter was $8.9 million, or $0.23 ... net loss for the same period in 2014, of $8.7 ... of March 31, 2015, cash, cash equivalents and investments totaled ...
(Date:4/30/2015)... Budapest, Hungary (PRWEB) April 30, 2015 ... electronic lab notebook with integrated protocols and specimen ... chemistry software solutions and consulting services for life ... the development of Labguru’s newest feature: chemical structure ... deep domain features for biologists, bio-chemists, and more, ...
Breaking Biology Technology:Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2Antibody Production Market worth $2.572 Billion by 2019 2Antibody Production Market worth $2.572 Billion by 2019 3Antibody Production Market worth $2.572 Billion by 2019 4Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 2Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 3Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 4Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 5Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 6Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 7Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 8Labguru Integrates ChemAxon's Marvin JS, to Enhance Functionality for Chemists 2
... , , MONTREAL , Jan. ... successful completion of a dose-ranging Phase 1 study and the ... combination with sorafenib for the treatment of patients with advanced ... "A Phase 2, Open-Label Study of The X-Linked Inhibitor of ...
... , , SHANGHAI ... Ltd., a,leading pharmaceutical R&D outsourcing Service Company in China ... Minster Jean-Pierre,Raffarin visited Sundia on January 22, 2010 . ... by Dr. Serge,Feneuille and Mr. Erwan Davoux ...
... LEIDEN, The Netherlands , January 26 ... are extremely,valuable for pharmaceutical research in the Netherlands . ... Top Institute, which was published today. In,the report, an independent ... is well on its way to achieving the objectives that ...
Cached Biology Technology:Aegera Therapeutics Initiates a Randomized Phase 2 Study with AEG35156 for the Treatment of Hepatocellular Carcinoma 2Former French Prime Minister Jean-Pierre Raffarin Visits Sundia 2Veerman Committee Argues for Continuation of TI Pharma 2
(Date:4/2/2015)... 2015 At its 2015 ACMG Annual Clinical ... , the American College of Medical Genetics and Genomics ... its Board.  Members of the ACMG Board of Directors ... and advancing its policies and programs. ACMG is the ... "It,s an eventful time in medical genetics and genomics.  ...
(Date:4/1/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market, announces the second shipment of a ... early access pre-order customers. Feedback from ... including Walmart, Target, AT&T, Dunkin, Donuts, Stop & Shop ... all outlets and very easy to use. Several users ...
(Date:3/31/2015)... 2015   Guidepoint , a leading global research ... Pain Management TRACKER, part of the Guidepoint TRACKER ... the medical device and therapeutics markets. The Post-Surgical Pain ... volumes, market share, and adoption rates across three major ... surgery. The Post-Surgical Pain Management TRACKER will ...
Breaking Biology News(10 mins):American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... is also available in Spanish . , ... levels becomes accustomed to the presence of an exogenous surplus, ... source--in this case, alcohol. , According to a study by ... the University of Granada , although there are no ...
... 2007 UT Southwestern Medical Center researchers have found that ... excludes a group of obese patients at risk of cardiovascular ... of the journal Surgery for Obesity and Related Diseases, ... between body mass index (BMI) and cardiovascular disease as it ...
... to induce cells to form parallel tube-like structures that could ... researchers found that they can control the cells, development by ... on the work was posted this month in an online ... one day be transplanted into tissues such as the kidneys, ...
Cached Biology News:A research of the UGR shows the genetic predisposition to develop alcohol abuse 2BMI criteria for obesity surgery should be lowered, UT Southwestern researcher suggests 2MIT works toward engineered blood vessels 2
Human/Mouse APLP-1 MAb (Clone 354020) ENTREZ GeneID: 333...
Mouse monoclonal [Flt-1/EWC] to VEGF Receptor 1 ( Abpromise for all tested applications). entrezGeneID: 2321 SwissProtID: P17948...
Mitotic Kinesin-Like Protein 1 (MKLP-1, KNSL5)...
Mouse Anti-Human MCAF-(MCP-1)...
Biology Products: